Skip to main content
CASE STUDY · YRI FELLOW
Ben Zhang
Ben ZhangSPORTS MEDICINE & AI

Predicting ACL injuries and recovery time in athletes, accepted at an IEEE conference

ACL tears are among the most common serious injuries in sport, and most research looks at anatomy while ignoring what athletes actually do in training. Ben built interpretable machine learning models, including Random Forest and Gradient Boosting, on basketball athlete performance data such as training hours and intensity. His work predicts not just the risk of a first-time ACL injury but also how long recovery will take, a question most existing studies treat as a fixed input rather than something to forecast.

FIELDSports Medicine & AI
RESULTFirst-author paper accepted at an IEEE conference
VENUEIEEE, 2026
Ben Zhang
Ben Zhang, YRI FellowIEEE
BEFORE THE FELLOWSHIP

A high school student and basketball fan who wanted to understand why ACL tears end so many athletic careers.

AFTER

First author of machine learning models that predict both ACL injury risk and recovery time from athlete performance data, accepted at an IEEE conference.

THE LEDGER
01First-author paper accepted at an IEEE conference
02Predicts first-time ACL injury risk, not just re-injury
03Forecasts recovery time, which most prior studies do not model
04Interpretable Random Forest and Gradient Boosting models on real training data
NEXT CASE STUDYManomay Jain, First-author paper accepted at an IEEE conference

Pick a program.Apply in minutes.

1,000+ students from 50+ countries
FREE TO APPLY · NO ESSAYS · DECISION IN 48 HOURS
$2,997 · 10 WEEKSThe Research FellowshipA published research paper.
  • A PhD mentor, 1:1 every week
  • Our team edits every draft with you
  • We get it published in IEEE, Springer or Elsevier
$9,997 · 8 FAMILIES A YEARThe Top 1% ProfileBuilt for Ivy League admissions.
  • Your whole college application, built with you
  • 2 to 3 papers and the full competition season
  • The founder works with your family personally
Apply for the Top 1% Profile

ROLLING ADMISSIONS · SEATS LIMITED · NOW REVIEWING